Skip to main content
    E

    Equillium Inc (EQ)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.21
    +0.06 (+5.22%)

    Market Cap: $94.67M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Equillium Inc (EQ) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Equillium (EQ) has a market cap of $94.67M. Its share count is up 213.34% from a year earlier. Revenue fell 100.00% over the last 12 months from the 12 months before.

    Total Valuation

    Market Cap$94.67M
    Latest price (Nov 17, 2026)$1.21

    Key Dates

    The next earnings report is expected on Mar 23, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 23, 2027 (expected)
    Last Earnings DateNov 12, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.11% in the quarter ended Sep 30, 2026 and grew 77.75% a year over 2 years.

    Shares Outstanding111.92M
    Shares Change (YoY)+213.34%
    Shares Change (QoQ)+0.11%
    Share Count Growth (2Y CAGR)+77.75%

    Valuation Ratios

    Sales and book value multiples are 30.8x and 2.6x. Its year-end P/S ranged from 0.7x to 2.3x from 2022 to 2024.

    P/S Ratio30.8x
    P/B Ratio2.6x

    Valuation history and multiples

    Price Statistics

    The stock is up 16.35% over 52 weeks and trades 21.43% below its 50-day average.

    Beta (1Y)1.32
    52-Week Change+16.35%
    1-Month Change-2.42%
    3-Month Change-48.07%
    6-Month Change-31.44%
    5-Year Change-78.29%
    Total Return (1Y)+16.35%
    Total Return (5Y CAGR)-25.31%
    Return vs SPY (1Y)+9.44%
    Max Drawdown (1Y)-64.06%
    Max Drawdown (3Y)-90.33%
    Sharpe Ratio (1Y)0.19
    Correlation with SPY (1Y)0.18
    50-Day Average$1.54
    200-Day Average$2.08
    52-Week Range$0.81 to $3.54
    RSI (14 Days)38.8
    Average Volume (20 Days)305.26K

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 19.49x current liabilities.

    Current Ratio19.49x
    Quick Ratio19.49x

    Returns and Efficiency

    Return on equity is -34.86% over the last 12 months, against a 5-year average of -86.75%.

    Return on Equity (ROE)-34.86%
    Return on Assets (ROA)-32.90%
    ROE (5Y Average)-86.75%
    ROA (5Y Average)-50.68%
    ROIC (5Y Average)-66.60%

    Scores

    EQ has an Altman Z-Score of 20.24, in the safe zone above 2.99, and a Piotroski F-Score of 1 of 9, in the weak band of 0 to 2.

    Altman Z-Score20.24
    Altman Z ZoneSafe
    Piotroski F-Score1 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue was $0 over the last 12 months.

    Revenue$0
    Revenue Growth (YoY)-100.00%
    Operating Income-$19.77M
    Pretax Income-$18.36M
    Net Income-$18.36M
    Reported EPS (TTM)-$0.18

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 94.39% of the $55.81M in total assets.

    Cash and Equivalents$53.32M
    Working Capital$52.13M
    Shareholder Equity$52.68M
    Book Value Per Share$0.47
    Total Assets$55.81M
    Total Liabilities$3.13M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $118.00K of capital spending, operating cash flow left -$15.48M of free cash flow.

    Operating Cash Flow-$15.37M
    Capital Expenditures$118.00K
    Free Cash Flow-$15.48M
    FCF Per Share-$0.19
    Depreciation and Amortization$97.00K

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Growth

    Revenue fell 79.79% a year over 3 years.

    Revenue Growth (3Y CAGR)-79.79%
    Book Value Per Share Growth (2Y CAGR)-30.38%
    Tangible Book Per Share Growth (2Y CAGR)-30.38%

    Revenue and profit by year

    Peer Position

    Against 5 similar companies, EQ has the 2nd highest P/S.

    P/S Ratio30.8x vs 4.0x median
    Revenue Growth (Trailing 4 Quarters, YoY)-100.00% vs -82.16% median

    Competitors compared

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewOvervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About EQ

    What is EQ's market cap?

    Equillium has a market cap of $94.67M.

    How many shares of EQ are outstanding?

    Equillium has 111.92M shares outstanding. The count is up 213.34% from a year earlier.

    Does EQ pay a dividend?

    No. Equillium does not pay a dividend.